{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T20:39:12Z","timestamp":1784320752756,"version":"3.55.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jocn-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jocn.2024.110927","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T13:49:26Z","timestamp":1732110566000},"page":"110927","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Stereotactic radiosurgery for pancreatic neuroendocrine tumor brain Metastases: Systematic review and Illustrative case presentation"],"prefix":"10.1016","volume":"130","author":[{"given":"Paul M.","family":"Harary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke S.","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyas","family":"Annagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Akhavan-Sigari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit R.L.","family":"Persad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Ustrzynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara C.","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armine","family":"Tayag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0005","doi-asserted-by":"crossref","first-page":"78","DOI":"10.6004\/jnccn.2015.0011","article-title":"Neuroendocrine tumors, version 1.2015","volume":"13","author":"Kulke","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0010","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.29099","article-title":"Exploring the rising incidence of neuroendocrine tumors: a population\u2010based analysis of epidemiology, metastatic presentation, and outcomes","volume":"121","author":"Hallet","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MPA.0b013e31828e34a4","article-title":"Consensus guidelines for the management and treatment of neuroendocrine tumors","volume":"42","author":"Kunz","year":"2013","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0020","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MED.0b013e328320d845","article-title":"Genetics and molecular pathology of neuroendocrine gastrointestinal and pancreatic tumors (gastroenteropancreatic neuroendocrine tumors)","volume":"16","author":"Oberg","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000486096","article-title":"The Evolution of Neuroendocrine Tumor Treatment Reflected by ENETS Guidelines","volume":"106","author":"Zandee","year":"2018","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10585-023-10250-6","article-title":"Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases\u2013data from a tertiary care center","volume":"41","author":"Popov","year":"2024","journal-title":"Clin Exp Metastasis"},{"issue":"9","key":"10.1016\/j.jocn.2024.110927_b0035","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/annonc\/mdq022","article-title":"Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)","volume":"21","author":"Garcia-Carbonero","year":"2010","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.jocn.2024.110927_b0040","first-page":"276","article-title":"Neuroendocrine tumours of the GI tract\u2013data from the German NET Registry","volume":"139","author":"Begum","year":"2012","journal-title":"Zentralbl Chir"},{"key":"10.1016\/j.jocn.2024.110927_b0045","doi-asserted-by":"crossref","unstructured":"Maiuri F, Cappabianca P, Del Basso De Caro M, Esposito F. Single brain metastases of carcinoid tumors. Journal of neuro-oncology. 2004;66:327-332.","DOI":"10.1023\/B:NEON.0000014517.56866.bc"},{"issue":"8","key":"10.1016\/j.jocn.2024.110927_b0050","article-title":"Stereotactic radiosurgery for carcinoid brain metastasis: a case report","volume":"11","author":"Cao","year":"2019","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.jocn.2024.110927_b0055","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/WNL.36.6.745","article-title":"Neurologic complications of carcinoid","volume":"36","author":"Patchell","year":"1986","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jocn.2024.110927_b0060","first-page":"2605","article-title":"Carcinoid metastasis to the brain. Cancer: Interdisciplinary International Journal of the American Cancer","volume":"101","author":"Hlatky","year":"2004","journal-title":"Society"},{"issue":"6","key":"10.1016\/j.jocn.2024.110927_b0065","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1148\/rg.306105523","article-title":"Pancreatic endocrine tumors: radiologic-clinicopathologic correlation","volume":"30","author":"Lewis","year":"2010","journal-title":"Radiographics"},{"key":"10.1016\/j.jocn.2024.110927_b0070","doi-asserted-by":"crossref","unstructured":"Man D, Wu J, Shen Z, Zhu X. Prognosis of patients with neuroendocrine tumor: a SEER database analysis. Cancer management and research. Published online 2018:5629-5638.","DOI":"10.2147\/CMAR.S174907"},{"issue":"44","key":"10.1016\/j.jocn.2024.110927_b0075","doi-asserted-by":"crossref","first-page":"e17773","DOI":"10.1097\/MD.0000000000017773","article-title":"The prognostic analysis of different metastatic patterns in pancreatic neuroendocrine tumors patients: A population based analysis","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.jocn.2024.110927_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5559-7","article-title":"Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome","volume":"19","author":"Krug","year":"2019","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.jocn.2024.110927_b0085","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1159\/000513249","article-title":"Unique metastatic patterns in neuroendocrine neoplasms of different primary origin","volume":"111","author":"Hermans","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/nop\/npx009","article-title":"Outcomes of stereotactic radiosurgery of brain metastases from neuroendocrine tumors","volume":"5","author":"Prayongrat","year":"2018","journal-title":"Neuro-Oncol Pract"},{"key":"10.1016\/j.jocn.2024.110927_b0095","article-title":"Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401)","author":"Kawabe","year":"2016125111","journal-title":"J Neurosurg"},{"issue":"6021","key":"10.1016\/j.jocn.2024.110927_b0100","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0105","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/path.4853","article-title":"Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D","volume":"241","author":"Simbolo","year":"2017","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-21-0152","article-title":"The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms","volume":"29","author":"Venizelos","year":"2022","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.jocn.2024.110927_b0115","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jocn.2024.110927_b0120","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/bjc.2016.229","article-title":"Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study","volume":"115","author":"Vijayvergia","year":"2016","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0125","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1038\/s41598-023-31759-6","article-title":"Pan-cancer genomic analysis shows hemizygous PTEN loss tumors are associated with immune evasion and poor outcome","volume":"13","author":"Vidotto","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2024.110927_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.921645","article-title":"Mutational profile and potential molecular therapeutic targets of pheochromocytoma","volume":"13","author":"Ma","year":"2022","journal-title":"Front Endocrinol"},{"issue":"6","key":"10.1016\/j.jocn.2024.110927_b0135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1136\/jcp.54.6.443","article-title":"The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas","volume":"54","author":"Lam","year":"2001","journal-title":"J Clin Pathol"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/modpathol.3801013","article-title":"Frequent loss of 17p, but no p53 mutations or protein overexpression in benign and malignant pheochromocytomas","volume":"21","author":"Petri","year":"2008","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0145","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/0284186X.2018.1564841","article-title":"Management of brain metastases from large cell neuroendocrine carcinoma of the lung: Improved outcomes with radiosurgery","volume":"58","author":"Wegner","year":"2019","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.jocn.2024.110927_b0150","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1016\/j.ijrobp.2020.07.2010","article-title":"Management of brain metastases from small cell lung cancer using SRS","volume":"108","author":"Koffler","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0155","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/1533034615589033","article-title":"Management of brain metastasis in patients with pulmonary neuroendocrine carcinomas","volume":"15","author":"Kotecha","year":"2016","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.jocn.2024.110927_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13256-021-02690-z","article-title":"Cerebral metastasis of Merkel cell carcinoma following resection with negative margins and adjuvant external beam radiation: a case report","volume":"15","author":"Grubb","year":"2021","journal-title":"J Med Case Reports"},{"issue":"12","key":"10.1016\/j.jocn.2024.110927_b0165","article-title":"The Evaluation and Treatment of Merkel Cell Carcinoma and Brain Metastasis","volume":"15","author":"Gaburak","year":"2023","journal-title":"A Case Report and Review of the Literature Cureus"},{"issue":"6","key":"10.1016\/j.jocn.2024.110927_b0170","article-title":"Neuroendocrine carcinoma of uterine cervix: Stereotactic radiotherapy for brain metastasis and stereotactic body radiotherapy for renal and pancreatic metastases","volume":"12","author":"Mori","year":"2020","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.jocn.2024.110927_b0175","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ygyno.2005.02.019","article-title":"Gamma-knife radiosurgery for the treatment of ovarian cancer metastatic to the brain","volume":"97","author":"Brown","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jocn.2024.110927_b0180","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11102-020-01074-8","article-title":"Treatment of sellar metastases with gamma knife radiosurgery in patients with advanced cancer","volume":"23","author":"Benjamin","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/j.jocn.2024.110927_b0185","doi-asserted-by":"crossref","DOI":"10.25259\/SNI_117_2022","article-title":"Cerebellopontine angle metastasis of a neuroendocrine tumor mimicking vestibular schwannoma: A case report","volume":"13","author":"Yamada","year":"2022","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.jocn.2024.110927_b0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11060-009-0025-z","article-title":"Pituitary metastasis of Merkel cell carcinoma","volume":"97","author":"Feletti","year":"2010","journal-title":"J Neurooncol"},{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12105-020-01164-w","article-title":"Primary parotid Merkel type small cell neuroendocrine carcinoma with oligometastasis to the brain and adrenal gland: case report and review of literature","volume":"15","author":"Young","year":"2021","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.jocn.2024.110927_b0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.inat.2017.08.003","article-title":"Cerebral metastasis of malignant pheochromocytoma 28 years after of disease onset","volume":"10","author":"Miyahara","year":"2017","journal-title":"Interdisciplinary Neurosurgery"},{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000523989","article-title":"Poorly Differentiated Neuroendocrine Carcinoma of Unknown Primary with Metastasis to the Testis: A Case Report","volume":"15","author":"Sano","year":"2022","journal-title":"Case Reports in Oncology"},{"key":"10.1016\/j.jocn.2024.110927_b0210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1\u2014Update and clarification: From the RECIST committee","volume":"62","author":"Schwartz","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jocn.2024.110927_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1999-x","article-title":"Clinicopathological analysis in patients with neuroendocrine tumors that metastasized to the brain","volume":"16","author":"Akimoto","year":"2016","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.jocn.2024.110927_b0220","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"issue":"18","key":"10.1016\/j.jocn.2024.110927_b0225","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.jocn.2024.110927_b0230","doi-asserted-by":"crossref","first-page":"e2124750","DOI":"10.1001\/jamanetworkopen.2021.24750","article-title":"Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.jocn.2024.110927_b0235","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jamcollsurg.2008.08.013","article-title":"Proposed staging system for colon carcinoid tumors based on an analysis of 2,459 patients","volume":"207","author":"Landry","year":"2008","journal-title":"J Am Coll Surg"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0240","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000287277","article-title":"ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors","volume":"91","author":"Pavel","year":"2010","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1078-0432.CCR-17-1921","article-title":"Molecular subtypes of pulmonary large-cell neuroendocrine carcinoma predict chemotherapy treatment outcome","volume":"24","author":"Derks","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jocn.2024.110927_b0250","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jtho.2018.02.002","article-title":"New insights into the molecular characteristics of pulmonary carcinoids and large cell neuroendocrine carcinomas, and the impact on their clinical management","volume":"13","author":"Derks","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0255","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1158\/1078-0432.CCR-19-0556","article-title":"The prognostic and therapeutic role of genomic subtyping by sequencing tumor or cell-free DNA in pulmonary large-cell neuroendocrine carcinoma","volume":"26","author":"Zhuo","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jocn.2024.110927_b0260","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/MPA.0b013e3181ec124e","article-title":"The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems","volume":"39","author":"Klimstra","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.jocn.2024.110927_b0265","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.jocn.2024.110927_b0270","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1002\/cam4.4809","article-title":"Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control","volume":"11","author":"Kanayama","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.jocn.2024.110927_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.590980","article-title":"Volumetric regression in brain metastases after stereotactic radiotherapy: time course, predictors, and significance","volume":"10","author":"Oft","year":"2021","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.jocn.2024.110927_b0280","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S1470-2045(20)30323-5","article-title":"Molecular profiling of neuroendocrine tumours to predict response and toxicity to peptide receptor radionuclide therapy","volume":"21","author":"Bodei","year":"2020","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.jocn.2024.110927_b0285","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2176\/nmc.30.476","article-title":"Brain and Skull Metastases of Hepatic or Pancreatic Cancer\u2014Report of Six Cases\u2014","volume":"30","author":"Kuratsu","year":"1990","journal-title":"Neurol Med Chir"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0290","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000092693","article-title":"Cerebellar Metastasis from Pancreatic Adenocarcinoma: A Case Report","volume":"6","author":"Caricato","year":"2006","journal-title":"Pancreatology"},{"issue":"01","key":"10.1016\/j.jocn.2024.110927_b0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/1793-5482.151507","article-title":"Brain metastasis from pancreatic cancer: a case report and literature review","volume":"10","author":"Matsumoto","year":"2015","journal-title":"Asian Journal of Neurosurgery"},{"key":"10.1016\/j.jocn.2024.110927_b0300","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1024337020884","article-title":"Nervous system involvement by pancreatic cancer","volume":"63","author":"Park","year":"2003","journal-title":"J Neurooncol"},{"issue":"12","key":"10.1016\/j.jocn.2024.110927_b0305","first-page":"4599","article-title":"Long-term survival following resection of brain metastases from pancreatic cancer","volume":"31","author":"Lemke","year":"2011","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.jocn.2024.110927_b0310","first-page":"90","article-title":"An extremely rare case of pancreatic cancer presenting with leptomeningeal carcinomatosis and synchronous intraparenchymal brain metastasis","volume":"6","author":"Rao","year":"2013","journal-title":"Gastrointestinal Cancer Research: GCR"},{"issue":"2","key":"10.1016\/j.jocn.2024.110927_b0315","doi-asserted-by":"crossref","first-page":"65","DOI":"10.15279\/kpba.2018.23.2.65","article-title":"Pancreatic cancer with brain metastases: case report with literature review","volume":"23","author":"Lee","year":"2018","journal-title":"The Korean Journal of Pancreas and Biliary Tract"},{"issue":"3","key":"10.1016\/j.jocn.2024.110927_b0320","article-title":"Stereotactic Radiosurgery in the Management of Brain Metastases: A Case-Based Radiosurgery Society Practice Guideline","volume":"9","author":"Ladbury","year":"2024","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.jocn.2024.110927_b0325","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1470-2045(14)70061-0","article-title":"Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study","volume":"15","author":"Yamamoto","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jocn.2024.110927_b0330","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.radonc.2018.12.018","article-title":"Volume not number of metastases: Gamma Knife radiosurgery management of intracranial lesions from an Australian perspective","volume":"133","author":"Izard","year":"2019","journal-title":"Radiother Oncol"},{"issue":"3","key":"10.1016\/j.jocn.2024.110927_b0335","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/cam4.1352","article-title":"The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery","volume":"7","author":"Routman","year":"2018","journal-title":"Cancer Med"},{"issue":"10","key":"10.1016\/j.jocn.2024.110927_b0340","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/MPA.0000000000000700","article-title":"Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors","volume":"45","author":"Qian","year":"2016","journal-title":"Pancreas"},{"issue":"3","key":"10.1016\/j.jocn.2024.110927_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031447","article-title":"Role of Somatostatin Signalling in Neuroendocrine Tumours","volume":"23","author":"Rogoza","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jocn.2024.110927_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-6498-z","article-title":"P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms","volume":"20","author":"Nielsen","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.jocn.2024.110927_b0355","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3892\/etm.2021.10613","article-title":"The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5","volume":"22","author":"Popa","year":"2021","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.jocn.2024.110927_b0360","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1038\/s41598-024-54599-4","article-title":"Somatostatin receptor 2 (SSTR2) expression is associated with better clinical outcome and prognosis in rectal neuroendocrine tumors","volume":"14","author":"Kim","year":"2024","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jocn.2024.110927_b0365","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1053\/j.gastro.2018.02.026","article-title":"Loss of chromatin-remodeling proteins and\/or CDKN2A associates with metastasis of pancreatic neuroendocrine tumors and reduced patient survival times","volume":"154","author":"Roy","year":"2018","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.jocn.2024.110927_b0370","doi-asserted-by":"crossref","first-page":"e3004","DOI":"10.1038\/cddis.2017.401","article-title":"Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading","volume":"8","author":"Cavalcanti","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jocn.2024.110927_b0375","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3389\/fonc.2018.00467","article-title":"Cell-free DNA from metastatic pancreatic neuroendocrine tumor patients contains tumor-specific mutations and copy number variations","volume":"8","author":"Boons","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2024.110927_b0380","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11060-004-8093-6","article-title":"Brain metastases: epidemiology and pathophysiology","volume":"75","author":"Gavrilovic","year":"2005","journal-title":"J Neurooncol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824004661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824004661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T16:31:29Z","timestamp":1738686689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586824004661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":76,"alternative-id":["S0967586824004661"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110927","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic radiosurgery for pancreatic neuroendocrine tumor brain Metastases: Systematic review and Illustrative case presentation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110927","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110927"}}